MwanzoCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Bei iliyotangulia
$ 163.69
Bei za siku
$ 159.65 - $ 163.00
Bei za mwaka
$ 159.65 - $ 275.00
Thamani ya kampuni katika soko
8.29B USD
Wastani wa hisa zilizouzwa
elfu 802.66
Uwiano wa bei na mapato
20.24
Mgao wa faida
-
Ubadilishanaji wa msingi
NYSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.01B | -1.64% |
Matumizi ya uendeshaji wa biashara | 219.42M | 5.38% |
Mapato halisi | 69.66M | -20.29% |
Kiwango cha faida halisi | 6.90 | -18.92% |
Mapato kwa kila hisa | 2.59 | -4.78% |
EBITDA | 236.55M | -4.13% |
Asilimia ya kodi ya mapato | 22.96% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 210.17M | 33.72% |
Jumla ya mali | 8.00B | 5.22% |
Jumla ya dhima | 4.18B | -1.88% |
Jumla ya hisa | 3.83B | — |
hisa zilizosalia | 51.14M | — |
Uwiano wa bei na thamani | 2.21 | — |
Faida inayotokana na mali | 4.65% | — |
Faida inayotokana mtaji | 5.62% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 69.66M | -20.29% |
Pesa kutokana na shughuli | 251.79M | 22.56% |
Pesa kutokana na uwekezaji | -21.32M | 73.20% |
Pesa kutokana na ufadhili | -207.54M | -27.43% |
Mabadiliko halisi ya pesa taslimu | 30.64M | 170.98% |
Mtiririko huru wa pesa | 223.49M | 120.91% |
Kuhusu
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1947
Makao Makuu
Tovuti
Wafanyakazi
21,100
